BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Delafloxacin: Phase IIb started

Rib-X began a double-blind, U.S. Phase IIb trial to compare 300 mg IV delafloxacin twice daily vs.15 mg/kg IV Zyvox linezolid or 600 mg IV Vancocin vancomycin twice...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >